|

Depression Clinical Trials in Arkansas

21 recruiting studies across 10 cities

All Trials in Arkansas

Phase
Trial Phase Location
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.Phase 3Bentonville
A Study to Evaluate the Effectiveness of DT-101 in Patients With DepressionPhase 2Bentonville
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.Phase 2Bentonville
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive DisorderPhase 3Bryant
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II DisorderPhase 2Bryant
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) InhibitorPhase 4Bryant
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 3Bryant
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 3Bryant
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsPhase 3Bryant
ALTO-100 in Bipolar Disorder With Depression (BD-D)Phase 2Fayetteville
E-Mindfulness Approaches for Living After Breast CancerPhase 3Fort Smith
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)Phase 3Little Rock
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderPhase 3Little Rock
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive DisorderPhase 2Little Rock
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With DepressionPhase 2Little Rock
Effectiveness, Implementation, and Cost of Cognitive Processing Therapy in PrisonsN/ALittle Rock
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive DisorderPhase 3Little Rock
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric PatientsPhase 3Little Rock
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 3Little Rock
Double-blind, Placebo-controlled Study in Adults With Major Depressive DisorderPhase 2Rogers
Study of ALTO-300 in MDDPhase 2Rogers

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.